Blood-Brain Barrier Remains Intact in Common Alzheimer's Disease Model, Challenging Old Beliefs
New research suggests that the blood-brain barrier remains largely intact in a common Alzheimer's disease mouse model, challenging previous beliefs about disease-related brain leakiness and informing future treatment strategies.
Recent research from Texas Tech University Health Sciences Center (TTUHSC) has provided new insights into the integrity of the blood-brain barrier (BBB) in Alzheimer's disease (AD). Traditionally, it was believed that AD causes the BBB to become 'leaky,' allowing harmful substances to infiltrate the brain and potentially worsening the disease. However, the latest study suggests that the BBB remains largely resilient in a popular mouse model of AD.
Conducted by a collaborative team from the TTUHSC Department of Pharmaceutical Sciences and Brain Drug Discovery Center, along with the Graduate School of Biomedical Sciences, the research focused on evaluating BBB permeability in Tg2576 mice, a widely used animal model that develops amyloid plaques typical of AD. The team used a highly sensitive technique called liquid chromatography-tandem mass spectrometry (LC-MS/MS) combined with laser microdissection to precisely measure the leakage of [¹³C₁₂]sucrose, a molecule that normally cannot cross an intact BBB.
The findings revealed that sucrose levels in the brains of aged and young Tg2576 mice remained extremely low, indicating minimal to no leakage across the BBB. This was consistent across critical regions involved in cognition and memory, and even around amyloid plaques, the 'mortar' proteins that seal the BBB appeared to stay intact.
These results challenge the longstanding assumption of widespread BBB disruption in AD. Instead, they suggest that the barrier retains its protective functions despite the presence of amyloid plaques. This has important implications for drug delivery strategies, as therapies aimed at penetrating the BBB may need to consider that the barrier is not broadly compromised in this disease model.
While these findings provide valuable insights, researchers emphasize that additional models mimicking human physiology more closely are necessary. The next steps include studying the effects of FDA-approved monoclonal antibodies on BBB integrity, especially regarding microhemorrhages or brain swelling that could cause localized leakages.
Understanding the resilience of the BBB in AD could significantly influence future therapeutic approaches and drug design, ultimately aiming for more effective treatments that respect the barrier's protective role. The study underscores the complexity of AD and highlights the importance of refining our models to better understand disease mechanisms.
Source: https://medicalxpress.com/news/2025-09-blood-brain-barrier-resilient-widely.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Semaglutide, a Weight-Loss Medication, Shows Promise in Reducing Cocaine Use in Animal Studies
New animal research suggests that semaglutide, a weight-loss drug, significantly reduces cocaine-seeking behavior, highlighting its potential as a future treatment for cocaine addiction.
Human–AI Collaborations Achieve Superior Accuracy in Medical Diagnoses
A recent study shows that combining human expertise with artificial intelligence leads to the most accurate medical diagnoses, promising new opportunities for healthcare decision-making and patient safety.
Potential Health Risks of Microplastic Contamination in Food
Research uncovers health concerns related to microplastic particles found in food, showing potential organ damage and metabolic disruptions from daily exposure.
The Influence of Bedding on Sleep Thermal Comfort and Insulation
Explore how bedding and sleep posture influence thermal insulation and comfort during sleep. A recent study uses advanced modeling to optimize sleep environments for better health and comfort.